BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35477541)

  • 1. Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers.
    Massen M; Lommen K; Wouters KAD; Vandersmissen J; van Criekinge W; Herman JG; Melotte V; Schouten LJ; van Engeland M; Smits KM
    Clin Epigenetics; 2022 Apr; 14(1):56. PubMed ID: 35477541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.
    Müller D; Győrffy B
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188722. PubMed ID: 35307512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
    Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
    Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
    Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
    PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
    Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
    Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?
    Feng Z; Oberije CJG; van de Wetering AJP; Koch A; Wouters KAD; Vaes N; Masclee AAM; Carvalho B; Meijer GA; Zeegers MP; Herman JG; Melotte V; van Engeland M; Smits KM
    Clin Transl Gastroenterol; 2022 Jun; 13(6):e00499. PubMed ID: 35584320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of quantifying
    Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
    Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer.
    Hu H; Wang T; Pan R; Yang Y; Li B; Zhou C; Zhao J; Huang Y; Duan S
    Pathol Oncol Res; 2019 Apr; 25(2):567-575. PubMed ID: 30368728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
    Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
    Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of exon methylation biomarkers for colorectal cancer via LC-MS/MS strategy.
    Huang Q; Yang Q; Mo M; Ye X; Zhang J; Zhang L; Chen B; Li J; Cai C
    J Mass Spectrom; 2017 Dec; 52(12):860-866. PubMed ID: 28940471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
    Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
    BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
    Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
    BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development.
    Kang B; Lee HS; Jeon SW; Park SY; Choi GS; Lee WK; Heo S; Lee DH; Kim DS
    Cancer Biomark; 2021; 32(2):231-236. PubMed ID: 34092617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
    Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.
    Barták BK; Kalmár A; Péterfia B; Patai ÁV; Galamb O; Valcz G; Spisák S; Wichmann B; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Molnár B
    Epigenetics; 2017 Sep; 12(9):751-763. PubMed ID: 28753106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.
    Rasmussen SL; Krarup HB; Sunesen KG; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    Colorectal Dis; 2016 Jun; 18(6):549-61. PubMed ID: 26998585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
    Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
    Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Biomarker-Combined Screening for Colorectal Cancer Based on Bisulfate Conversion-Free Detection of Fecal DNA Methylation.
    Liu C; Xu L; Li W; Jie M; Xue W; Yu W
    Biomed Res Int; 2021; 2021():1479748. PubMed ID: 34621892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.